Bone Sarcomas, Financial Toxicity
Conditions
Brief summary
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.
Detailed description
Measure the prevalence of financial toxicity and the severity of it in orthopaedic oncology patients undergoing surgical intervention using an objective, validated instrument. Secondary objectives include identifying socioeconomic and demographic risk factors for financial toxicity and evaluating clinicopathologic characteristics that may worsen financial stress in this population.
Interventions
OTHERdata collection
data collection from electronic health records
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified. * Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.
Exclusion criteria
• Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaires | Through study completion; an average of 1 year |
Countries
United States
Contacts
CONTACTShalin S Patel, MD
PRINCIPAL_INVESTIGATORShalin S Patel, MD
M.D. Anderson Cancer Center
Outcome results
None listed